13-1-7　ⓔ文献

  1. 竹内　勤：関節リウマチ．日本内科学会雑誌，2010; 99: 2392–2400.

  2. 竹内　勤：関節リウマチの治療の進歩．日本内科学会雑誌，2012; 101: 647–653.

  3. 竹内　勤：〈特集〉関節リウマチ (RA)：診断と治療の進歩．Editorial関節リウマチ：診断と治療法の進歩．日本内科学会雑誌，2012; 101: 2815–2817.

  4. 竹内　勤，金子祐子：関節リウマチにおけるTreat to target．日本内科学会雑誌，2014; 103: 2321–2327.

  5. Smolen JS et al: EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease–modifying antirheumatic drugs: 2019 update. Ann Rheum Dis, 2020; 79; 685–699.

  6. 竹内　勤：関節リウマチ治療の最新の進歩と今後の課題．内科学会雑誌，2015; 104: 1773–1782.

  7. Takeuchi T: Treatment of rheumatoid arthritis with biological agents–as a typical and common immune–mediated inflammatory disease. Proc Jpn Acad Ser B Phys Biol Sci, 2017; 93: 600–608.

  8. Takeuchi T, Kameda H: The Japanese experiences with biologic therapies for Rheumatoid Arthritis. Nature Rev Rheum, 2010; 6: 644–652.

  9. Takeuchi T: Biomarkers as a treatment guide in rheumatoid arthritis. Clin Immunol, 2018; 186: 59–62.

  10. Tasaki S: Multi–omics monitoring of drug response in rheumatoid arthritis: in pursuit of molecular remission. Nat Commun, 2018; 9: 2755.